In this study, a meta-analysis of randomized controlled trials comparing ursodeoxycholic acid (UDCA) monotherapy with combination therapies utilizing UDCA and budesonide was performed. We found that combination therapy with UDCA and budesonide was more effective than UDCA monotherapy for primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Moreover, compared to prednisone, budesonide has fewer side effects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304592 | PMC |
| http://dx.doi.org/10.2147/DDDT.S74515 | DOI Listing |
Publication Analysis
Top Keywords
combination therapy
8
ursodeoxycholic acid
8
overlap syndrome
8
udca monotherapy
8
udca budesonide
8
therapy ursodeoxycholic
4
budesonide
4
acid budesonide
4
budesonide pbc-aih
4
pbc-aih overlap
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!